Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
26.97
+0.93 (3.55%)
At close: Sep 11, 2026, 4:00 PM EDT
27.50
+0.54 (1.98%)
After-hours: Sep 11, 2026, 7:54 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $284.51 million as of September 11, 2026. Its market cap has increased by 271.99% in one year.
Market Cap
284.51M
Enterprise Value
326.31M
1-Year Change
271.99%
Ranking
Category
Stock Price
$26.97
ChartMarket Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $284.51M, a decrease of -15.40%. That is a compound annual growth rate of -2.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 284.51M | 425.91% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Personalis | 1.75B |
| Freenome | 1.69B |
| OPKO Health | 1.15B |
| Castle Biosciences | 987.05M |
| Fulgent Genetics | 546.18M |
| Myriad Genetics | 305.12M |
| Exagen | 177.09M |
| Insight Molecular Diagnostics | 134.17M |